Primary lung lymphoma involving the superior vena cava by Sen Wei et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Wei et al. World Journal of Surgical Oncology 2012, 10:131
http://www.wjso.com/content/10/1/131CASE REPORT Open AccessPrimary lung lymphoma involving the superior
vena cava
Sen Wei, Xin Li, Xiaomin Qiu, Honglin Zhao, Gang Chen, Jun Chen* and Qinghua Zhou*Abstract
Primary lung lymphoma (PLL) presenting as a primary pulmonary lesion is rare and usually affects elderly people.
Here we describe a 25-year-old Chinese man diagnosed with primary lung lymphoma, which presented as a huge
lung tumor mimicking a primary lung cancer and involving the superior vena cava. He underwent double-sleeve
reconstructions of bronchus and pulmonary arteries with right upper- and middle-lobe lobectomy along with
replacement of the superior vena cava with a graft, and was then given standard chemotherapy of CHOP plus
Rituximab. The patient has been well, showing no local recurrence or distal metastasis during a 27-month follow-up.
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Primary lung lymphoma (PLL) is a rare distinct entity
(0.4% of all lymphomas) that usually affects elderly
patients [1-3]. Generally, these cases are difficult to diag-
nose accurately because of a nonspecific clinical and
radiological presentation. On the other hand, they have
relatively satisfactory outcomes, especially in cases ame-
nable to surgical resection. Owing to the rarity of PLL,
standard treatment protocols have not yet been opti-
mized, and there is no guideline as to when surgery is
indicated.
Herein, we present a young patient with a rare primary
pulmonary lymphoma (diffuse large B cell lymphoma,
DLBCL) mimicking a primary lung cancer and involving
the superior vena cava. He was treated by double-sleeve
reconstructions of bronchus and pulmonary arteries with
right upper and middle lobe lobectomy, and replacement
of the superior vena cava with a graft.
Case presentation
A 25-year-old Chinese male was admitted because of re-
spiratory symptoms and a large mass on the computed
tomography (CT) scan suggestive of primary lung carcin-
oma. This patient presented with 45 days of an irritating
dry cough and right chest pain without other abnormal* Correspondence: huntercj2004@yahoo.com; zhouqh1016@yahoo.com.cn
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reproduction in any medium, provided the orfindings such as fever, wheezing, hemoptysis, or superior
vena cava syndrome. He had no smoking history and no
family history of lung cancer. A review of systems was
noncontributory. On admission, peripheral blood count,
serum chemistry, and urinalysis were normal.
An enhanced chest CT scan revealed a huge pulmon-
ary tumor over the right upper lung field with medias-
tinal and hilar lymphadenopathy surrounding the right
upper lobe bronchus. Angiography showed encroach-
ment on the superior vena cava (Figure 1). Abdominal
CT, MRI scan of the brain, and a bone scan were all nor-
mal. Bronchoscopy showed a subsegmental bronchus of
the right upper lobe being pressured from outside with-
out mucosal invasion, and bronchoscopic biopsy did not
show any malignancy. Before hospitalization, the patient
had undergone a CT-guided fine-needle aspiration bi-
opsy in another medical center and a preoperative di-
agnosis of squamous cell carcinoma was made. This
conclusion later proved to be a misdiagnosis.
On 21 December, 2009, after establishment of a venous
bypass between the right internal jugular vein and the
right femoral vein, a surgical exploration was performed
through a standard posterolateral incision under general
anesthesia. There was a huge tumor (18 × 16× 15 cm3)
located in the right upper lobe surrounding the roots of
the right upper lobe bronchus and invading the sur-
rounding tissues and organs, including part of the right
middle lobe, the middle and lower portion of the superior
vena cava, the right side of the pericardium, the right. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Enhanced chest CT scan before operation. (A) In the mediastinal window, the CT scan revealed the tumor encroaching on the
superior vena cava (right panel), surrounding the right upper lobe bronchus (middle panel), and invading the right pulmonary artery (left panel).
(B) In the lung window. (C) In the mediastinal window, coronal.
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(Figure 2A). Several oval nodules found at the same time
in the middle lobe were suspected to be metastatic
lesions. Mediastinal and hilar lymph nodes were enlarged
and had a tendency to integration. Intraoperative frozen
section of lymph node sampling proved all of them to be
metastatic poorly differentiated carcinoma.
Based on these findings, sleeve lobectomy of the right
upper and middle lobes was performed successfully to
achieve complete tumor resection. Portions of the surgi-
cal procedure were sophisticated, including sleeve re-
section and reconstruction of the right bronchus and
pulmonary artery, reconstruction of the superior vena
cava, partial resection of the pericardium, and systematicFigure 2 The images during the operation. (A) Gross features of the 15-
left is from the right innominate vein (RIV) to the superior vena cava (SVC);
atrium (RA).mediastinal lymphadenectomy (Figure 2B). Postoperative
histopathological assessment of the huge lobulated gray-
yellow lung mass revealed that the tumor was situated in
the lung parenchyma and involved visceral pleura. The
tumor cells exhibited large vesicular nuclei and frequent
mitoses without tumor necrosis. Immunohistochemically,
the tumor cells expressed CD20, CD23, CD30, CD43,
Kappa, and MUM1, but not CD117, TdT, CD10, or Bcl-6.
The proliferation fraction as determined by staining with
Ki-67 was 80%. Based on these findings, the diagnosis of
diffuse large B cell lymphoma (Figure 3) was made. The
diagnosis of PPL was based on characteristic histological
and immunophenotypical features according to the Kiel
classification and the WHO classification [4]. Mediastinalcm mass in right upper-middle lobes. (B) SVC grafts: the graft on the
the graft on the right is from the left innominate vein (LIV) to the right
Figure 3 Histopathological images (×100 and ×400). (A) Hematoxylin and eosin (H&E) staining of primary lung lymphoma. (B)
Immunohistochemical staining of primary tumor with antibodies to CD20, CD30, CD23, and CD43. (C) Immunohistochemical staining of primary
tumor with antibodies to Kappa, mum-1, and Ki67.
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contained tumor. All of the negative surgical margins
(bronchus, pulmonary artery, and superior vena cava)
were confirmed. The tumor was determined to be stage
IIE by the Ann Arbor classification system [5].
Five weeks after the operation, the patient received ad-
juvant therapy with CHOP (cyclophosphamide, Adriamy-
cin, vincristine and prednisone) and Rituximab (a
humanized monoclonal anti CD-20 antibody) for six cy-
cles. For economic reasons, he did not receive mainten-
ance therapy of Rituximab. After a 27-month follow-up
period, as shown in Figure 4 for16-month after oper-
ation, the patient is well and without evidence of locally
recurrent or distal disease.
Discussion
Extranodal lymphomas account for 24% to 48% of NHL,
and primary pulmonary lymphomas are infrequent
(about 3.6% among all extranodal lymphomas) [2]. Pri-
mary pulmonary lymphoma (PPL) is defined as a clonal
lymphoid proliferation affecting one or both lungs (par-
enchyma and/or bronchi) in a patient with no detectable
extrapulmonary involvement at diagnosis or during the
subsequent 3 months [6,7]. According to the World
Health Organization’s classification system, the most
common histological subtypes of primary pulmonary
lymphoma are low-grade lymphomas (75-88%), and the
second most frequent histological type of lymphoma to
involve the lung is diffuse large B-cell lymphoma
(DLBCL), which represents only about 5-20% of primarypulmonary lymphomas [8]. The high-grade B-cell PPLs
usually spread rapidly into mediastinal and extra-
thoracic locations. The case of DLBCL we reported here
presented as a huge lung tumor mimicking a primary
lung cancer involving the superior vena cava.
Primary pulmonary lymphoma is most commonly seen
in between the 5th and 7th decades of life, with a mean
age of 50 years and a male-to-female ratio of 1.07:1 [9].
The present case was a young (25-year-old) man with
nonspecific symptoms of irritating dry cough and right
chest pain. As reported previously, PPLs can present
with nonspecific symptoms [10]. Since PPLs can present
with different radiological manifestations, an accurate
diagnosis is often not easy. In our case, the images were
suggestive of locally advanced lung cancer, but the final
diagnosis turned out to be a primary pulmonary lymph-
oma. This further emphasizes the importance of histo-
logical diagnosis of lung lesions, although this tumor was
even misdiagnosed as lung cancer before operation based
on pathological findings from CT-guided fine-needle as-
piration biopsy. In the literature, preoperative CT-guided
fine-needle aspiration biopsy allows diagnosis of PPL in
only 25% of patients [11]. Thus, in order to avoid the
mistake of the misdiagnosis of this curable disease, it is
important to keep in mind that any radiological abnor-
mality of the lung parenchyma may be a lymphoproli-
ferative disorder, which sometimes has a good prognosis
and has a very different management plan from epithelial
neoplasia of the lung, especially when the lung is primar-
ily affected [12].
Figure 4 Chest X-ray and CT scan after operation. (A) The chest x-ray images of the patient before/after operation. (B and C) The chest CT
scan 16 months after the operation. The red lines show the SVC replacement graft.
Wei et al. World Journal of Surgical Oncology 2012, 10:131 Page 4 of 5
http://www.wjso.com/content/10/1/131High-grade pulmonary B-cell lymphoma is far rare and
usually occurs in individuals with an underlying disorder
(e.g., immunodeficiency). The prognosis is poor com-
pared with low-grade lymphoma, and therapeutic
options depend on the underlying disorder. Because of
its rarity, relatively little is known about the biological
characteristics of DLBCL. Treatment of these rare tu-
mors is poorly standardized. Several treatment options
are available, including tumor resection, surgery with ad-
juvant chemotherapy, or chemotherapy alone. The opti-
mal treatment remains controversial, but the prognosis
can be relatively excellent [13]. One large series of 70
patients reported a 94% survival at 5 years for low-grade
primary pulmonary lymphoma, and a median survival of
3 years for high-grade disease [10]. Another series with
48 patients reported a 68% 5-year survival for primary
pulmonary MALT lymphoma and a 65% 5-year survival
for non-MALT lymphoma [3].
We believe surgery should be the treatment of choice
if a complete resection can be achieved. The potential
surgical candidate could be any patient with locallyresectable tumor up to stage IIE. Lymph node involve-
ment does not appear to be a contraindication to surgery
[14]. To our knowledge, few patients with pulmonary
DLBCL involving the superior vena cava have received
radical surgical treatment, so this is an extremely un-
common case. Although some authors have recom-
mended a pneumonectomy for multiple lesions of low-
grade PPL involving one lung, in our view this option
may be too aggressive because of the indolent course of
the disease. One patient reported by Frederic et al. [15]
is still alive after a 36-month follow-up.
Treatment after surgical resection is often based on a
combination chemotherapy regimen. Diffuse large B cell
lymphoma is frequently treated by CHOP (cyclophos-
phamide, Adriamycin, vincristine and prednisone), and
Rituximab may improve the response to CHOP treatment,
as has been shown in systemic diffuse large B-cell lymph-
oma. Although survival is worse for patients with high-
grade PPL than for those with low-grade PPL, published
reports show that more than half of patients with high-
grade PPL can achieve survivals of 8 to 10 years [16].
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In conclusion, surgery should be the treatment of choice
in cases of localized PPL when complete resection can
be achieved.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images.
Competing interests
The authors declare that they have no competing interests.
Authors’ contribution
SW performed research, analyzed data, and wrote the paper; XL, HLZ, XMQ,
and GC collected the data and followed up the patient; JC performed
operation and research, analyzed data, and wrote the paper; QHZ performed
operation and revised the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
This study was partly supported by grants from the Science and Technology
Support Key Program of Tianjin (09ZCZDSF04100, 09ZCZDSF04000) and the
project of Ministry of Education for New Century Excellent Talents
(NCET-10-0956).
Received: 8 February 2012 Accepted: 3 June 2012
Published: 30 June 2012
References
1. Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF: Lymphosarcoma: A
review of 1269 cases. Medicine 1961, 40:31–84.
2. Freeman C, Berg JW, Cutler SJ: Occurrence and prognosis of extranodal
lymphomas. Cancer 1972, 29:252–260.
3. Ferraro P, Trastek VF, Adlakha H, Deschamps C, Allen Ms, Pairolero PC:
Primary non-Hodgkin’s lymphoma of the lung. Ann Thorac Surg 2000,
69:993–997.
4. Harris NL, Jaffe ES, Stein H, et al: A revised European-American
classification of lymphoid neoplasms: a proposal from the International
Lymphoma Study Group. Blood 1994, 84:1361–1392.
5. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the
Committee on Hodgkin’s Disease Staging Classification. Cancer Res 1971,
31:1860–1861.
6. Cadranel JWM, Antoine M: Primary Pulmonary Lymphoma. Eur Respir J
2002, 20:750–762.
7. Kim JH, Lee SH, Park J, Kim HY, Lee SI, Park JO, Kim K, Kim WS, Jung CW,
Park YS, Im YH, Kang WK, Lee MH, Park K, Han JH, Ko YH: Primary
pulmonary non-Hodgkin’s lymphoma. Jpn J Clin Oncol 2004, 34:510–514.
8. Nicholson AG, Harris NL: Primary pulmonary diffuse large B-cell
lymphoma. In World Health Organization classification of tumours. Pathology
and genetics. Tumours of the lung, pleura, thymus and heart. Edited by Travis
WD, Brambilla E, Muller-Hermelink HK, Harris CC. Lyon: IARC Press; 2004:91.
9. Li G, Hansmann ML, Zwingers T, Lennert K: Primary pulmonary lymphoma
of the lung: Morphological, immunohistochemical and clinical features.
Histopathology 1990, 16:519–531.
10. Cordier JF, Chailleux E, Lauque D, et al: Primary pulmonary lymphomas: a
clinical study of 70 cases in nonimmunocompromised patients. Chest
1993, 103:201–208.
11. Pisani RJ, DeRemee RA: Clinical implications of the histopathologic
diagnosis of pulmonary lymphomatoid granulomatosis. Mayo Clin Proc
1990, 65:151–163.
12. Hu RL, Li H: Giant cystic hemolymphangioma of the postmediastinum.
Thoracic Cancer 2010, 1:175–177.
13. Mattedi RL, Bernardi Fdel C, Bacchi CE, Siqueira SA, Mauad T: Fatal outcome
in bronchus-associated lymphoid tissue lymphoma. J Bras Pneumol 2007,
33:487–491.
14. Eckardt J, Olsen KE, Petersen H: Metastasis in the subcarinal lymph node
with unknown primary tumor. Thoracic Cancer 2011, 2:69–70.15. Vanden Eynden F, Fadel E, de Perrot M, de Montpreville V, Mussot S,
Dartevelle P: Role of surgery in the treatment of primary pulmonary
B-cell lymphoma. Ann Thorac Surg 2007, 83:236–240.
16. L’Hoste RJ Jr, Filippa DA, Lieberman PH, Bretsky S: Primary pulmonary
lymphomas. A clinical pathologic analysis of 36 cases. Cancer 1984,
54:1397–1406.
doi:10.1186/1477-7819-10-131
Cite this article as: Wei et al.: Primary lung lymphoma involving the
superior vena cava. World Journal of Surgical Oncology 2012 10:131.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
